Cerovations, LLC is a Minnesota medtech developer focused on linking promising medical device inventions to non-dilutive grant funding, and then commercializing the technologies to corporate strategic partners with established sales channels. The primary focus is on neurosurgical inventions, but medical devices within other fields of practice will be considered if the IP is strong, the de-risking milestone is clear, and the value proposition is compelling. Cerovations licensed its first University of Minnesota medical device invention in the summer of 2018, and then filed for a Phase I SBIR grant in January of 2019. By September, news of the grant award was delivered to Cerovations. By that time, a 2nd license had been negotiated from the University of Minnesota, and a 2nd SBIR grant submission had been filed. The business strategy is to rely on federal grant funding to develop early stage inventions such that they are de-risked enough for licensing or acquisition.